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Larva migrans has been recognized as a dermatitis associated with hot weather
along the eastern seaboard for the past twenty years or more, particularly along
the southeastern seaboard. Treatment has always been, at best, difficult,
and painful and often prolonged.
Dr. Kirby-Smith and his associates in 1926 (1) first drew attention to this disease and
prepared a classic monograph on the subject. Reports since then (2—4) show that cases of
creeping eruption have been acquired in every state of the coastal plains extending from
New Jersey through Texas. Doubtful cases (5, 6) have been reported in Oklahoma, Ken-
tucky and Manitoba but in neither of the latter two instances was the parasite demon-
strated. Some of my patients have acquired the infection in South Carolina and have then
gone on a trip before noticing any manifestation of the eruption. By the time the eruption
became manifest, at least one of these patients was seen and treated in the state of New
York. Such instances (8) will probably be noted more frequently in the future and must
be traced back to the original source of infection rather than credit the eruption to the state
in which the manifestation first appears.
Kirby-Smith (7) saw twenty five hundred cases over a period of years in Jacksonville,
Florida. The writer has seen and treated in his own practice not less than an average of a
hundred to a hundred and fifty cases of the condition during the past fourteen summers.
The incidence of the eruption seems to be somewhat dependent upon the amount of moisture
in the soil and the massiveness of exposure to the infection as well as to the patient's coming
in contact with damp ground where stray cats, dogs, and other pets are allowed.
The form of creeping eruption discussed in this review is due to the burrowing action of
the third stage ifiariform larvae of Ankylostoma braziliense, a hookworm found in dogs and
cats. Human infection takes place on exposure to moist sandy soil contaminated b be
feces of infected animals. Frequent sources of infection are moist sand above tide h.vel,
garden plots and the edges of fresh water lakes. Almost any damp earthy spots providing
suitable conditions for the hatching of hookworm larvae and accessible to infected animals
may become a source of creeping eruption. The larva enters into the skin of any part of the
body but most commonly the hands and feet. The back and buttocks are also frequently
the original site of entry. The eruption has been found on all parts of the body. Belding
(9) describes the points of invasion as reddish itchy papules, from which develop within
two or three days narrow linear, slightly elevated erythematous, serpiginous intracutaneous
tunnels formed by the migration of the larvae which may move a distance of inches in a day.
Vesicles form along the course of the tunnels and the surface becomes dry and crusty.
Itching is intense and scratching often leaves a secondary infection. The disease must
be differentiated from similar eruptions. The size of the burrow is dependent in many
cases upon the reaction of the host's skin. The papulo-vesicular eruption of "ground itch",
due to the hookworm, Necator americanus, is readily recognized. In the creeping erup-
tion due to a fly larva of the Gastrophilus group, the lesion is less complex and longer than
in infections due to A. braziliense. This eruption has been reported from middle western
states and the central part of Canada, but not from the coastal states of the eastern and
southern United States.
Severe multiple infection of creeping eruptions have been noted, particularly in mechan-
ics who have lain on the damp ground under automobiles and in plumbers and electricians
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who have been forced to crawl in sand under houses and come in intimate contact with
possible larvae areas. I have noted many cases of infection with the burrows on the geni-
talia and around the anus but have never had a single case in which the larvae followed the
mucous membranes into these organs. Dr. Howard Hailey of Atlanta reports one case in
which the larva burrowed up into the urethra. Dr. Joseph M. Hitch (10) has seen one case
of entry into the rectal mucosa.
The incidence of this infection seems to vary a good deal with the weather. In very dry
seasons it has been my experience that the number of cases has been remarkably lessened
while in exceptionally wet summers the number of cases is markedly increased.
For many years the treatment of larva migrans consisted of local destruction of the
larvae. The measures used for this purpose vary from the most satisfactory method of
freezing with a pencil of solid carbon dioxide snow to the use of olfactory agents on the skin.
Onion poultice therapy has been proposed in the last several years by Dr. Hailey. An old
fashioned South Carolina back country remedy has been to take a piece of "fat-back" or
pork rind and bind it on the area for two or three days at a time. I do not believe that this
has ever been very efficacious. Also, methods of injection of novocaine, chloroform and
phenol have been advocated but have been very painful and not too helpful. Perhaps one
of the simplest measures is to incise the end of the burrow and with a high-power magnifying
glass to try to pick out the larva mechanically. This is not easy to do. For the past ten
or twelve years I have been using a small quarter-inch diameter pencil of carbon dioxide
snow and have been freezing the ends of the burrows for some four to fifteen seconds, de-
pending on the thickness of the skin in the area treated. Inmost cases this is satisfactory,
although it is painful and a blister must be raised to achieve success. Some scarring is also
incident upon this method of treatment. It is not completely satisfactory and often results
in the substitution of a rather large number of blisters on the skin for the itching of the
burrowing larvae themselves. Since the larvae are difficult to eradicate in one or two treat-
ments, the pruritus associated with the creeping eruption itself is complicated by the added
pain of the treatment burns. Ethyl chloride is not only inefficient in this respect but is ex-
pensive and in many cases is often not continued long enough to raise a blister. Unless a
blister is formed, the larva is usually not destroyed and is merely stimulated to greater
efforts and activity. This was noted by Dr. Chad. M. Andrews and has been used by him
and by others as a method of diagnosis, in that the stimulation of larval activity by light
freezing of ethyl chloride brings out the typical eruption sooner than might be the case
otherwise.
When only one lesion or two or three larval trails are found in a patient, it is frequently
quicker and easier to freeze the lesions than to use any other method of treatment. Cer-
tainly this is true of most of the systemic therapy which has been advocated in the past.
The systemic therapy of larva migrans and other tropical diseases has received a good
deal of study in the last several years and has been stimulated considerably by the war-time
experience in the tropics. Four kinds of chemical compounds (11) show promise of leading
to treatment of value in some of the larva conditions which effect the body. Filariasis has
been one of the conditions which has been studied rather thoroughly. The chemicals which
have proven of some value are the antimony group of which Fuadin is also a member;
arsenical compounds such as Mapharsen; the cyanamine dyes; and the piperazines. Be-
cause Fuadin (antimony bis-eatechol disulfonate of sodium) had already proven useful in
protozoal diseases, Smith decided to try it in a two and a half year old boy who presented
the eruption in the foot and in the perineal and perianal areas. He gave daily intramuscular
injections of 2cc. of Fuadin solution for five days. The eruption began to clear up after the
first two or three doses of the first series and was entirely gone by the time the fifth dose was
administered. The second series was begun but stopped after three doses at the mother's
request since the child seemed entirely well and was sleeping all night. There was no re-
currence.
In 1934 Cawstori (12) had tried antimony potassium tartrate without success in creeping
eruption. Blank (13) tried Fuadin in several eases of creeping eruption with failure, and
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Dolce and Franklin (14) found the treatment somewhat disappointing. Wilson (15) and
Rubin (16) used the treatment and found it definitely helpful. They were enthusiastic
about the use of this treatment. Wilson used rather large doses of 5 cc. in each injection in
a series of seven cases and had no trouble. Diarrhea seems to be the only complication of
this method of treatment. Hitch (17) in a careful study of thirty-three eases found that
both antimony and arsenical compounds showed larvistatic and larvicidal activity. In his
series he found that oxophenarsine hydrochloride was somewhat superior to the other drugs.
The antimony compounds require injection intravenously as do the cyanamine dyes.
All of these drugs have certain toxic effects and must be used with a considerable degree
of care. The piperazines have been tried and are the subject of this paper. In 1947 Dr.
Arturo L. Carrion (11), while studying the effect of the piperazines on filariasis, was curious
about its possible effect against larva migrans. He treated a case with 2 mgs. of Hetrazan
per kilogram of body weight three times a day and found that the lesions and subjective
symptoms disappeared. He discontinued treatment and the eruption recurred. Treat-
ment was resumed and extended over a period of three weeks after which time there was no
recurrence for a period of five months of observation. The drug in my series of cases was
used on nineteen patients of different ages and was found to be quite satisfactory. It was
given by mouth and in the series reported caused very few side effects.
Hetrazan, or diethylcarbamazine, (19, 20, 21, 22) was found by Hewitt and
his co-workers to be an effective filaricide in experimental animals and this
study was later extended to man. The use of piperazines in medicine is not new.
For more than a decade prior to 1918 piperazine and 3,6-dimethylpiperazine
were accepted remedies for gout and rheumatism. Although these drugs were
worthless in these diseases, the years of use served to establish the low toxicity
of the nucleus and to provide excellent descriptions of the symptoms of over-
dosage.
1-Diethylcarbamyl-4-methyipiperazine hydrochloride, also called Hetrazan
and 84-L has a molecular weight of 234.6 (19, 21) and has the following struc-
tural formula:
112112
C—C 0 C2H5/ \ /
CH3—N N—C—N HCL\ /
C—C C2H5
112H2
It is a colorless crystalline solid, highly soluble in water, alcohol, and chloro-
form, but insoluble in benzene, ether, and petroleum ether. The pH of a 1.0
per cent solution is 4.1. Thorough and careful toxicity studies in mice, rats
and dogs showed that the intraperitoneal LD 50 in mice was 248 mg. per kilo-
gram and in rats 465 mg. per kilogram. The oral LD 50 in mice was 660 mg. per
kilogram and in rats, 1,380 mg. per kilogram. The compound is not irritating,
it produces no local anesthesia, and has no effect on eyes, isolated uterus or
intestine, nor on the blood sugar in laboratory animals. It is mildly diuretic
and analgesic. Blood pressure is not effected. The drug is rapidly excreted
through the kidneys.
The systemic reactions exhibited (18) during the treatment with Hetrazan
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with therapeutic doses have been dependent largely upon the type of infection
treated. Doses of 2 mgs. per kilogram body weight three times daily adminis-
tered to patients effected with Ascaris, or to patients not effected with worms of
any kind, have not produced disturbing side reactions. Slight headaches, or a
mild malaise, lasting for a few hours may occur. In this particular series of
patients, nausea and loss of appetite in one patient was the only noticeable side
effect. Wuchereria bancrofti patients show various other symptoms during
treatment, such as testicular or scrotal pains, fever, pain in the joints, back or
legs, eosinophilia, lymplangitis and general malaise. Patients infected with
Onchocerca volvulus, a ifiaria parasite in Mexico and Guatemala, exhibit severe
reactions after very low doses of Hetrazan (0.5 mgs. per kilogram). Marked
facial edema, intense pruritus and swelling of the arms have occurred in this
infection. In severe infections the simultaneous death of a large number of
worms may possibly provoke the more disturbing symptomatology. The
toxicity of Hetrazan per se in doses ranging from 0.5 to 2.0 mgs. per kilogram
three times daily for from one to three weeks, is very slight according to our
present information. The drug appears to be excreted rapidly, and is not
cumulative.
CASE REPORTS
Case 1: J. G., 4 year old white boy picked up his infection in the country 1 week before
being seen, On examination he had multiple infestation with burrows of some 20 to 30
larvae scattered diffusely over the calves and shins. Pruritus was intense and sleep im-
possible. Previous therapy consisted of sulfathiazole ointment and calamine lotion with
no help. Temperature was normal and minimal secondary infection was present. He was
given it milligrams Hetrazan per kilogram of weight for 24 hours. At that time the itching
had diminished greatly and the rate of travel of the larvae was much slower. The dose was
increased to 2 mgm. per kilo and maintained for 12 days. On the sixth day of treatment
there was slight extension of some of the burrows but the itching remained under control
and from the seventh day onward, no further symptoms were noted. The patient slept well
and there were no discernible side effects. No local treatment was used except sulfathiazole
ointment which had been previously used by the parents.
Case: R. N., 10 year old white boy, had a multiple infestation on the plantar and dorsal
surfaces of the right foot for four days. Source of infection was apparently in a city yard.
The number of larvae was estimated at four or five. Pruritus was intense, sleep poor, and
there was minimal secondary infection. He was given 1 mgm. Hetrazan per kilo of body
weight thrice daily for forty eight hours, then 2 mgms. per kilo for five more days. There
was no change in the itching nor in the rate of travel of the burrows during the first forty
eight hours. On increasing the dose to 2 mgms. per kilo thrice daily the itching immediately
eased and in forty eight hours the extension of the burrows stopped. On the seventh day,
the medicine ran out and the mother stopped the treatment. Twenty four hours later, the
traveling of the larvae recurred and the itching again became distressing. On the twelfth
day, the patient returned to the office, Hetrazan was resumed in a dosage of 2 mgms. per
kilo body weight t.i.d. and in twenty four hours both the progression of the burrows and
the itching had ceased. The treatment was continued for six days and no recurrence has
been noted since that time. On the twelfth day, one burrow was frozen for 8 seconds with
dry ice, a small blister was formed and no further extension of this lesion was noted.
Case 3: P. H., white girl baby 17 months age. Eruption for eight days, picked up on
damp ground in city. Bismuth violet solution and patent medicines had been used locally.
On examination, burrows of six to eight larvae were found over the dorsal surfaces of the
feet and ankles. The baby could not sleep. There was moderate secondary infection.
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Hetrazan was given in 0.5 mgm. per kilo body weight thrice daily for 24 hours. No change
was noted and the dose was increased to 1 mgrn. This was continued for seven days. The
rate of travel slowed down somewhat on the second day and remained very slight thereafter.
The itching was stopped as far as could be determined on the second day and was apparently
completely controlled thereafter. On the eight day, the dose was increased to 2 mgm.
One burrow which had slowly but definitely extended was at this time frozen with dry ice
pencil for 8". The two mgm. dose was continued through the twelfth day of therapy and
then stopped. There has been no recurrence of the trouble.
Case4: E. W., white boy five years old. He acquired his infection above tide level on a
barrier island at the seacoast one week previously. The parents used Ronone and several
other applications. The pruritus was severe, the patient could not sleep, but the secondary
infection was minimal. The eruption was on the bottom and side of the left foot. Only
one larva was found. He was given Hetrazan, 1 mgms. per kilo per body weight thrice
daily. The itching was well controlled in 24 hours but there was slow extension and the
mother was impatient so the single lesion was frozen with dry ice. Cryotherapy was suc-
cessful and no recurrence was noted. The Hetrazan had definite effect on the itching and
slowed the rate of travel but was not allowed to act for a long enough period of time to
produce definite results.
Case5: E. D., 15 year old negro boy, acquired two larval burrows three weeks previously
while in the country. The eruption was a distinct long linear tortuous set of two burrows on
the fiexural surface of the left wrist. It has been incised by the family physician and treated
with gentian violet. Secondary infection when first seen was minimal. He was given li
mgms. per kilo of body weight thrice daily for ten days. In 24 hours the itching had almost
stopped and remained controlled until the end of the period of treatment. The rate of
travel slowed and in 48 hours had stopped completely. On the eleventh day therapy was
stopped. On the 16th day and the 21st day there had been no recurrence.
Ca8e6: W. D. A., white boy 1 years of age, three to four burrows on the dorsum of the
right and left feet for three days. Infestation was apparently acquired in a city yard.
There was severe pruritus, poor sleeping, and minimal secondary infection. He was given
2 mgms. per kilo body weight thrice daily. In 24 hours the itching had apparently stopped
but the extension of the burrows was still evident. In 48 hours the burrow extension
stopped. The treatment was continued for six days, during which time the eruption re-
mained quiescent and under control. At this time, the mother had to leave the state.
Case 7: B. S. A., white man, 50 years old. He acquired his infestation while gardening
in the country three weeks previously. Various ointments were used without result. He
had from 4 to 7 larval burrows on the dorsum of the left foot and ankle. The itching was
severe, his sleeping was poor. Secondary infection was minimal. He was given 2 mgms.
per kilo body weight thrice daily. During the ensuing three days, there was no change in
either the itching nor the rate of extension of the burrows. On the fourth and fifth days
there was a definite increase in extension and itching, in spite of continued dosage of 2 mgms.
per kilo. On the fifth day, the dosage was increased to 3 mgms. per kilo t.i.d. and in twenty
four hours both the itching and the extension had stopped. On the tenth day the eruption
was under control and drying up rapidly. There were no side effects of any kind.
Case8: A. K., white girl 14 years old. She acquired her infestation in Florida, three days
before coming to the office. The burrows (two larvae) were on the dorsum of the right foot.
There was moderate itching and minimal secondary infection. She was able to sleep fairly
well. She was given 2 mgms. per kilogram body weight thrice daily. In 48 hours the itch-
ing was much milder and on the fifth day stopped almost entirely for the remainder of the
treatment period. The rate of extension of the burrows remained unchanged for the first
four days, then almost stopped. At this time, because the patient was leaving the city, the
ends of the visible burrows were frozen with dry ice pencils for 8 seconds. She reported by
mail on the tenth day that the foot was healing and that no further extension had occurred.
Case No. 9: D. B., negro boy 4 months old with a linear burrow on the medial surface
of the right thigh of three days duration. Two lesions were noted. Acquired on damp
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ground in the country. Itching was apparently severe enough to interfere markedly with
sleep but there was only minimal secondary inflammation. On the day of examination the
hemoglobin was 11 grams (73%), the white blood cell count was 14,200, polys 23%, lympho-
cytes 72%, eosinophils 2% and the red blood cell count was 5,050,000. Urine could not be
obtained either then or later. The child was placed on Hetrazan 2 mgms. per kilo body
weight thrice daily. After 48 hours the child no longer scratched at the area and thereafter
remained under apparent control. There was no change in the rate of extension for forty
eight hours and then stopped for the remainder of the period of treatment. The treatment
was continued for 9 days and then discontinued. There was recurrence on the tenth day
which responded to the resumption of therapy in two days. The treatment was continued
for 24 days altogether and then stopped. During the last five days the mother noted a defi-
nite loss of appetite and restlessness. On the ninth day the blood was again studied and
showed 11 grams hemoglobin with 11,200 white cells, 35% polys, 59% lymphocytes, 2%
eosinophiles, and a red blood cell count of 4,100,000. This patient was seen again on the
32nd day with a mild recurrence of the same burrow. The eruption was terminated by
cryotherapy.
Case 10: J. L. C., white girl aged 6 years who acquired her infestation in Florida three
weeks previously on the plantar surface of the right foot. It had been treated with ethyl
chloride freezing. The itching was severe and the child could not sleep. There was
marked secondary infection. The child was placed on Hetrazan 1 mgm. per kilo body
weight thrice daily for nine days. In 24 hours the itching had become mild and in three
days had almost stopped. The rate of travel was unchanged during the first 48 hours and
then stopped entirely. On the third day, the dose was increased to 1* mgms. per kilo body
weight thrice daily and continued for the remainder of the nine days treatment. The
eruption and itching remained under control and treatment was stopped on the tenth day.
Sixteen and 21 days later there was no recurrence.
Case 11: J. R., white woman age 43 acquired an infestation of three or four larvae on
the little finger of the left hand while gardening. The itching was severe and interfered
with sleep. There was moderate secondary infection. She was placed on 2 mgms. Hetrazan
per kilo t.i.d. for forty eight hours. On the second day the itching had become mild and
the travel stopped. However, on the third day both the itching and travel increased in
spite of continuance of the drug. The dose was increased to 4 mgm. per kilo but she was able
to take only one dose. She was slightly nauseated and was unable to take food although she
felt hungry. There was no headache or dizziness. She stopped the drug and 40 hours later
was again able to eat and felt perfectly well. In the meantime, on the seventh day the
eighth day and the tenth day the burrows were frozen with dry ice pencils. In only
one case was the freezing successful and the other larval trails were so interlaced as to be
indistinguishable from each other. On the thirteenth day she was asked to try again 1 mgm.
per kilo of the drug. She experienced no ill effects.
Case 1L H. B., white man 24 yrs old, acquired a larval infestation two weeks previously
on a sea island. The eruption consisted of 3 or 4 larval burrows on the dorsum of the left
foot. The lesion had been treated with ethyl chloride freezing, potassium permanganate
wet dressings, and mercury ointment. The itching was severe, sleep poor and there was
minimal secondary infection. The temperature was normal, red blood cell count 4,800,000,
white cell count 7,800, 70% polymorphonuclears, 39% lymphocytes, and 1% eosinophiles.
The urine was normal. He was given 2 mgms. Hetrazan per kilo body weight thrice daily
and reported that the itching was almost stopped in 24 hours. In forty eight hours, the
travel stopped for a day but then returned and increased. The itching remained mild
however. The drug was continued and on the seventh day both the itching and the travel
stopped. On the eighth day, the dose was increased to 3 mgs. per kilo t.i.d. On the twelfth
day, the dose was increased to 4 mgms. per kilo t.i.d. The single larva was still active and
continued to travel. The activity was terminated with cryotherapy.
Case 13: B. A. M., 13 months old baby girl, presented several larval burrows on the
vulvae. This was apparently acquired in damp ground in a city yard. The burrows had
been present for one week and had been treated with ointments. The child slept poorly
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and continually scratched herself. There was no secondary infection. Fletrazan was given
in a dosage of 1 mgm. per kilo body weight thrice daily, for four days. On the second day,
both the itching and the travel had apparently ceased. The drug was stopped and in twenty
four hours the larval activity and itching returned. The dose was then increased to 2 mgms.
per kilo body weight t.i.d. and in twenty four hours the activity was again stopped. The
dosage was continued for four days and then stopped. There has been no recurrence.
Case 14: F. F., white girl 8 years old. She acquired the larval infestation in a country
yard, playing barefoot. There has been the same creeping eruption in this child and her
younger brother for the past three years. They had been treated in the past with ethyl
chloride by the family physician. Hemoglobin was 85% Dare method. She was placed on
2 ingms. of Hetrazan per kilogram body weight t.i.d. In twenty four hours the itching and
the travel had stopped. On the sixth day there had been no recurrence of activity and the
lesions were drying up. The treatment was continued for 1,5 days, but after the ninth day
there was no further extension itching or activity.
Case15: G. F., white boyS yrs. old, acquired a larval infestation two weeks before, while
playing barefoot in damp country ground. There was only one burrow on the dorsum of the
left foot. The itching was moderate, he slept fairly well and there was no secondary in-
fection. He was placed on 2 mgms. Hetrazan per kilo bodyweight t .i .d. The treatment was
continued for 12 days and there was no recurrence. The itching and travel stopped in 72
hours.
Case 16: J. G., white boy age 4 years, acquired one larval burrow on the buttock. Prob-
able source of infection was the yard. Itching was moderate, sleep was fair and there was
no secondary infection. The patient had the eruption for two days. The patient was given
2 mgm. of Hetrazan per kilogram body weight thrice daily. Itching was improved in forty
eight hours and stopped after seventy two hours while travel stopped completely on the
fifth day and has not recurred.
Case17: A. W. W., white man 59 yrs of age who acquired his infection while seeding a wet
lawn with new grass. He had five burrows on the left hand. Itching was marked, sleep
only fair, and there was minimal secondary infection. Previous therapy with ethyl chloride
had not helped. He was given 1 xngm. Hetrazan for 48 hours with no improvement. The
dose was then increased to 2 mgm. per kilogram thrice daily and the itching was reduced con-
siderably but not altogether. The treatment was continued for eight days with moderate
relief but still some itching and extension. On the ninth and tenth days the dose was in-
creased to 4 milligrams per kilogram body weight but this made the patient nauseated and
tired there was aching in all the joints. The treatment was thereupon discontinued and
the burrows were outlined and the sites of larval infection were frozen and refrozen several
times to cure the eruption. This case is one of distinct failure as far as chemotherapy was
concerned.
Case 18: T.D., white boy age 7, acquired his infection while playing in the yard in damp
ground. There were an estimated 25 burrows on the extensor surface of the right forearm
with severe itching. The patient was unable to sleep. There was moderate secondary in-
fection. The eruption had been present more than three weeks. 2 mgms. of Hetrazan per
kilogram body weight thrice daily was given. The itching became much less marked in 24
hours and by the fourth day there was no further extension of the lesions. Treatment was
continued for 10 days and then discontinued. There was no recurrence.
Case1.9: T. S., white boy age 11, had three burrows on the left foot for one month. There
was moderate itching, sleep was fair and there was no secondary infection. He was given
2 mgm. Hetrazan per kilogram body weight thrice daily for eight days. The itching and the
travel stopped on the second day and there has been no recurrence.
DISCUSSION
The majority of the infestations occurred on either the feet or the hands.
The legs were involved in the case of marked multiple infection, and single
cases of vulvar, thigh and finger involvement were found.
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The age of the patients varied from 4 months to 43 years of age, with the
teen ages predominating. The age did not seem to affect the toxicity of the
drug nor did the age seem to require any variation in dosage, the average dose
of 2 mglns. per kilogram of body weight thrice daily, preferably after meals,
seeming to be the optimum amount.
The number of larval infestations in each case varied from 1 to about 30,
and this did not seem to influence the toxicity of the drug. In other larval and
protozoal diseases the amount of infestation has a definite bearing on the de-
velopment of toxic symptoms. In this series, the only toxic manifestations
noted occurred in a woman of 43 years of age who had three larval burrows on
TABLE I
CASE NifltS5R ITCHING MILD hOSING STOOPED
hours days
1 15—30 24 48 hours 4
2 4 24 48 " 6
3 6—8 24 24 " 4
4 1 24 24 " 1
5 1 24 48 " 2
6 3 24 24 " 3
7 5 6days
8 2 24 4 " 4
9 2 24 48 hours 2 days later recur-
rence—failure
10 3—5 24 48 " 2
11 3—4 no relief no relief Failure
12 3—5 24 4days 6
13 2 48 48 hours 2
14 1 24 24 " 1
15 1 24 48 " 2
16 1 24 48 5
17 5 48 never complete Failure
18 25 24 3days 1
19 3 48 48 hours 2
Average...... 6 24 48 hours 3
the hand and finger, whereas the ease with 15 to 30 burrows showed no differ-
ence in reaction or toxicity from the many cases with two or three burrows.
The toxic manifestations occurred when the dose was raised to 4 mgms. per kilo.
The patient was later able to take smaller doses without trouble. The cases
in which carbon dioxide pencil freezing was added were previously watched until
definite improvement had resulted from the treatment with Hetrazan alone.
One was then treated with cryotherapy because the mother was impatient,
another after six days of treatment because she was leaving for another state,
and there was still some possibility of activity, and the other three cases be-
cause activity was not affected by the drug and further therapy was needed.
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The dosage varied from 0.5 milligrams of the drug thrice daily to 3 milligrams
thrice daily. There was definitely less effect and slower response when .5 to 1
milligram thrice daily was used. Definite increase and acceleration of response
occurred when the dose was increased to 2 or 3 milligrams thrice daily. The
average response to therapy in the tables was somewhat prolonged by early
use of smaller doses. Even in the four months old baby there was no evidence
of toxicity from the full dosage.
From a study of the recurrences during therapy and cessation of therapy
which were found in three cases, it becomes evident that there is a definite
TABLE II
C AGE SITES IRY TOXIC SYMPTOMS RESULTS
days
1 4 yrs. Legs 15—30 2 12 None Cured
2 10 yrs. Feet 4 1 to 2 17 None Cured
3 17 mos. Feet 7 to 2 20 None Cured
4 5 yrs. Foot 1 it 6 None Cured
5 15 yrs. Wrist 2 2 10 None Cured
6 18 mos. Foot 4 2 10 None Cured
7 50 yrs. Foot 4—6 2 to 3 15 None Cured
8 14 yrs. Foot 2 2 to 3 12 None Cured
9 4 mos. Thigh 2 2 24 Loss appe- Failure
tjte
10 6 yrs. Foot 3—S 1 9 None Cured
11 43 yrs. Hand 3—4 2 4 Nausea, loss Failure
appetite
mala,ise
12 24 yrs. Foot 3—4 2 to 3 10 None Cured
13 13 rnos. \Tulvae 2 1 to 2 10 None Cured
14 8 yrs. Foot 1 2 9 None Cured
15 5 yrs. Foot 1 2 9 None Cured
16 4 yrs. Natal 1 2 11 None Cured
17 59 yrs. Hand 5 2 to 4 10 None except Failure
on highest
dose
18 7 yrs. Forearm 25 2 10 None Cured
19 11 yrs. Foot 3 2 8 None Cured
larvistatic effect from the first few days of treatment and that complete larvi-
cidal effects require continuation of therapy for seven days or more. This
was the case in the patient treated by Dr. Carrion. One of the patients in my
series, a white boy aged 10 yrs., took the treatment of 1 milligram per kilo body
weight thrice daily for two days, then 2 mgs. per kilo t.i.d. for five more days.
At this time, the supply of drug given to the patient was exhausted and no
treatment was taken for five days. Within twenty four hours there was a
definite recurrence. This persisted until five more days of therapy was adminis-
tered. In the second case, while there was a distinct and good response in the
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first three days of therapy, the drug had to be discontinued because of nausea,
lack of appetite and malaise. As soon as the therapy was stopped, the favor-
able effects were lost. In the third case, a 13 months old baby girl, the treat-
ment consisted of 1 mgm. per kilo body weight thrice daily for four days with
excellent response. The drug was then resumed in 2 mgm. doses per kilo body
weight for four more days and there was then no further resumption of activity.
It would seem therefore that the attainment of definite larvicidal action re-
quires a continued dosage of not less than seven days. The average duration of
treatment in this series was ten days, varying from three to twenty days. An
average duration of therapy of two weeks with no interruptions in therapy
would seem to be optimal. An average dosage of two milligrams per kilogram
body weight thrice daily during this period of time gave the best results.
However, the very definite relief from itching within twenty four to forty
hours attests the larvistatic action of the drug and makes its use worthwhile,
from that standpoint alone. With the acute pruritus relieved, continued use
for a week or two usually leads to complete larvicidal effects.
It is somewhat difficult to evaluate completely the treatment of creeping
eruption until more control studies of the average life cycle and duration of
larval activity without any treatment at all is known.
It is also quite possible that several different strains of larvae are involved
in these cases. There are marked variations in symptoms, e.g., acuteness of
the dermatitis, degree of larval activity, and presence of a papular form which
does not always eventuate in linear tortuous burrows. Further studies remain
to be made.
Variations in therapeutic activity of the drug might depend on the type of
infection and also on the rate of excretion of the drug in the host.
In summarizing the results, two of the cases were not continued long enough
to provide a proper test of the drug. When the remaining seventeen cases
are considered, with three distinct failures in therapy, a favorable percentage
of both larvistasis and larvicidal activity is found in 76.4% of the cases. This
is sufficient, in view of the marked ease of administration in tablet form by
mouth and the lack of serious toxic symptoms and side effects, to justify further
study in a large series of cases.
SUMMARY
A new larvicidal and larvistatic drug has been tried with promising results
in a series of nineteen cases of creeping eruption. Thirteen out of seventeen
cases which completed the course of treatment, 76.4%, were cured by its use.
In the dosage used, there were no toxic side effects, or they were negligible.
The drug is easily administered by mouth and does not require parenteral
injection. Effective larvistasis was achieved in forty eight hours and cure
in from seven to ten days.
Trial in an extended series of cases would appear to be well worth while.
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